Physician profile
Eric B Purdom
NPI 1053398339
$7,739.80
in general payments reported to CMS, 2019-2025
45 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $694 · 2021: $896 · 2022: $2,281 · 2023: $959 · 2024: $957 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,215.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,181.38 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,002.43 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $632.20 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Genzyme Corporation | $596.94 | 2019-2025 | |
| Amgen INC. | $584.88 | 2021-2025 | Tezspire |
| Grifols USA, LLC | $532.13 | 2021-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $351.63 | 2019-2025 | |
| Genentech USA, INC. | $316.01 | 2019-2025 | Xolair |
| Regeneron Healthcare Solutions, INC. | $286.27 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.94 | 2019-2021 | |
| Philips North America LLC | $179.51 | 2019-2025 | Patient Interface Software |
| Electromed, INC. | $170.20 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $167.95 | 2020-2025 | Glassia, Eohilia |
| Mylan Specialty L.P. | $132.30 | 2019-2023 | Yupelri |
| Intersect Ent, INC. | $130.80 | 2021 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $112.60 | 2022 | |
| Acclarent, INC | $110.41 | 2019-2023 | Relieva Tract, Trudi Nav Cable |
| Novartis Pharmaceuticals Corporation | $108.78 | 2021-2024 | |
| Harmony Biosciences LLC | $100.48 | 2023-2024 | Wakix |
| Aerin Medical INC. | $77.59 | 2022-2025 | |
| Smith+Nephew, INC. | $75.19 | 2019-2025 | Halo, Tula, Ent Sinus |
| Baxter Healthcare | $69.45 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Optinose US, INC. | $59.12 | 2021-2024 | |
| United Therapeutics Corporation | $56.98 | 2020-2024 | Tyvaso, Orenitram |
| Advanced Respiratory, INC | $49.64 | 2019 | |
| Organogenesis INC. | $39.86 | 2020-2023 | Puraply |
| Actelion Pharmaceuticals US, INC. | $38.28 | 2022-2024 | Uptravi, Opsumit |
| Stryker Corporation | $38.14 | 2020-2023 | Chromophare F300 |
| Vertex Pharmaceuticals Incorporated | $31.31 | 2025 | |
| Abbvie INC. | $28.01 | 2023 | |
| Revance Therapeutics, INC. | $26.14 | 2024 | Daxxify |
| Polynovo North America LLC | $25.98 | 2023 | |
| Checkpoint Surgical, INC | $25.45 | 2024 | Checkpoint Stimulators |
| Davol INC. | $22.88 | 2021 | |
| Pulmonx Corporation | $22.31 | 2022 | |
| Integra Lifesciences Corporation | $20.19 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $19.64 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mayne Pharma Commercial LLC | $19.13 | 2022 | |
| Kaleo, INC. | $17.34 | 2022 | |
| Medtronic, INC. | $14.84 | 2022 | |
| Insmed, INC. | $14.80 | 2025 | Arikayce |
| Merck Sharp & Dohme LLC | $13.63 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.30 | 2021 | |
| Allergan, INC. | $11.32 | 2019 | |
| Ambu INC. | $4.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Purdom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.